{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:17:38Z","timestamp":1790288258457,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Maternal immune activation can increase the vulnerability of the offspring to develop neuroimmune and behavioral abnormalities in response to stress in puberty. In offspring of immune-challenged mothers, stress-induced inflammatory processes precede the adult onset of multiple behavioral dysfunctions. Here, we explored whether an early anti-inflammatory intervention during peripubertal stress exposure might prevent the subsequent emergence of adult behavioral pathology. We used an environmental two-hit model in mice, in which prenatal maternal administration of the viral mimetic poly(I:C) served as the first hit, and exposure to sub-chronic unpredictable stress during peripubertal maturation as the second hit. Using this model, we examined the effectiveness of the tetracycline antibiotic minocycline (MINO) given during stress exposure to block stress-induced inflammatory responses and to prevent subsequent behavioral abnormalities. We found that combined exposure to prenatal immune activation and peripubertal stress caused significant deficits in prepulse inhibition and increased sensitivity to the psychotomimetic drugs amphetamine and dizocilpine in adulthood. MINO treatment during stress exposure prevented the emergence of these behavioral dysfunctions. In addition, the pharmacological intervention blocked hippocampal and prefrontal microglia activation and interleukin-1\u03b2 expression in offspring exposed to prenatal infection and peripubertal stress. Together, these findings demonstrate that presymptomatic MINO treatment can prevent the subsequent emergence of multiple behavioral abnormalities relevant to human neuropsychiatric disorders with onset in early adulthood, including schizophrenia. Our epidemiologically informed two-hit model may thus encourage attempts to explore the use of anti-inflammatory agents in the early course of brain disorders that are characterized by signs of central nervous system inflammation during development.<\/jats:p>","DOI":"10.1038\/tp.2016.38","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T13:48:23Z","timestamp":1459864103000},"page":"e772-e772","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia"],"prefix":"10.1038","volume":"6","author":[{"given":"S","family":"Giovanoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Richetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Feldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schedlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"key":"BFtp201638_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuron.2009.09.002","volume":"64","author":"BE Deverman","year":"2009","unstructured":"Deverman BE, Patterson PH . Cytokines and CNS development. Neuron 2009; 64: 61\u201378.","journal-title":"Neuron"},{"key":"BFtp201638_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.biopsych.2013.10.003","volume":"75","author":"AK McAllister","year":"2014","unstructured":"McAllister AK . Major histocompatibility complex I in brain development and schizophrenia. Biol Psychiatry 2014; 75: 262\u2013268.","journal-title":"Biol Psychiatry"},{"key":"BFtp201638_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/1073858406296401","volume":"13","author":"U Meyer","year":"2007","unstructured":"Meyer U, Yee BK, Feldon J . The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist 2007; 13: 241\u2013256.","journal-title":"Neuroscientist"},{"key":"BFtp201638_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","volume":"167","author":"AS Brown","year":"2010","unstructured":"Brown AS, Derkits EJ . Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010; 167: 261\u2013280.","journal-title":"Am J Psychiatry"},{"key":"BFtp201638_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jamapsychiatry.2013.896","volume":"707","author":"R Parboosing","year":"2013","unstructured":"Parboosing R, Bao Y, Shen L, Schaefer CA, Brown AS . Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry 2013; 707: 677\u2013685.","journal-title":"JAMA Psychiatry"},{"key":"BFtp201638_CR6","doi-asserted-by":"publisher","first-page":"e1447","DOI":"10.1542\/peds.2012-1107","volume":"130","author":"H\u00d3 Atlad\u00f3ttir","year":"2012","unstructured":"Atlad\u00f3ttir H\u00d3, Henriksen TB, Schendel DE, Parner ET . Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics 2012; 130: e1447\u2013e1454.","journal-title":"Pediatrics"},{"key":"BFtp201638_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/GRF.0b013e3182510b7b","volume":"55","author":"J Johnson","year":"2012","unstructured":"Johnson J, Anderson B, Pass RF . Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol 2012; 55: 521\u2013530.","journal-title":"Clin Obstet Gynecol"},{"key":"BFtp201638_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1203\/00006450-199707000-00001","volume":"42","author":"O Dammann","year":"1997","unstructured":"Dammann O, Leviton A . Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997; 42: 1\u20138.","journal-title":"Pediatr Res"},{"key":"BFtp201638_CR9","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/dneu.22043","volume":"72","author":"L Harvey","year":"2012","unstructured":"Harvey L, Boksa P . Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders. Dev Neurobiol 2012; 72: 1335\u20131348.","journal-title":"Dev Neurobiol"},{"key":"BFtp201638_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.biopsych.2013.07.011","volume":"75","author":"U Meyer","year":"2014","unstructured":"Meyer U . Prenatal poly(I:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 2014; 75: 307\u2013315.","journal-title":"Biol Psychiatry"},{"key":"BFtp201638_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-244X-13-97","volume":"13","author":"S Larsson","year":"2013","unstructured":"Larsson S, Aas M, Klungs\u00f8yr O, Agartz I, Mork E, Steen NE et al. Patterns of childhood adverse events are associated with clinical characteristics of bipolar disorder. BMC Psychiatry 2013; 13: 97.","journal-title":"BMC Psychiatry"},{"key":"BFtp201638_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/schbul\/sbs050","volume":"38","author":"F Varese","year":"2012","unstructured":"Varese F, Smeets F, Drukker M, Lieverse R, Lataster T, Viechtbauer W et al. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull 2012; 38: 661\u2013671.","journal-title":"Schizophr Bull"},{"key":"BFtp201638_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1126\/science.1228261","volume":"339","author":"S Giovanoli","year":"2013","unstructured":"Giovanoli S, Engler H, Engler A, Richetto J, Voget M, Willi R et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 2013; 339: 1095\u20131099.","journal-title":"Science"},{"key":"BFtp201638_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/jmg.2008.061796","volume":"46","author":"TV Bilousova","year":"2009","unstructured":"Bilousova TV, Dansie L, Ngo M, Aye J, Charles JR, Ethell DW et al. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 2009; 46: 94\u2013102.","journal-title":"J Med Genet"},{"key":"BFtp201638_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/sj.jcbfm.9600268","volume":"26","author":"CZ Lee","year":"2006","unstructured":"Lee CZ, Yao JS, Huang Y, Zhai W, Liu W, Guglielmo BJ et al. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J Cereb Blood Flow Metab 2006; 26: 1157\u20131164.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFtp201638_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-2094-5-15","volume":"5","author":"CJ Henry","year":"2008","unstructured":"Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 2008; 5: 15.","journal-title":"J Neuroinflammation"},{"key":"BFtp201638_CR17","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/cercor\/bhs151","volume":"23","author":"M Hinwood","year":"2013","unstructured":"Hinwood M, Tynan RJ, Charnley JL, Beynon SB, Day TA, Walker FR . Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline. Cereb Cortex 2013; 23: 1784\u20131797.","journal-title":"Cereb Cortex"},{"key":"BFtp201638_CR18","doi-asserted-by":"publisher","first-page":"124548","DOI":"10.1155\/2012\/124548","volume":"2012","author":"SS Siller","year":"2012","unstructured":"Siller SS, Broadie K . Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome. Neural Plast 2012; 2012: 124548.","journal-title":"Neural Plast"},{"key":"BFtp201638_CR19","first-page":"175","volume":"38","author":"D Mattei","year":"2014","unstructured":"Mattei D, Djodari-Irani A, Hadar R, Pelz A, de Cossio LF, Goetz T et al. Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia. Brain BehavImmun 2014; 38: 175\u2013184.","journal-title":"Brain BehavImmun"},{"key":"BFtp201638_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuroscience.2014.01.021","volume":"266","author":"F Zhu","year":"2014","unstructured":"Zhu F, Liu Y, Zheng Y, Zhao J . Minocycline alleviates behavioral deficits and inhibits microglial activation induced by intrahippocampal administration of Granulocyte-Macrophage Colony -Stimulating Factor in adult rats. Neuroscience 2014; 266: 275\u2013281.","journal-title":"Neuroscience"},{"key":"BFtp201638_CR21","doi-asserted-by":"publisher","first-page":"e93966","DOI":"10.1371\/journal.pone.0093966","volume":"9","author":"F Zhu","year":"2014","unstructured":"Zhu F, Zheng Y, Ding YQ, Liu Y, Zhang X, Wu R et al. Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats. PLoS One 2014; 9: e93966.","journal-title":"PLoS One"},{"key":"BFtp201638_CR22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.psychres.2014.06.046","volume":"219","author":"F Zhu","year":"2014","unstructured":"Zhu F, Zheng Y, Liu Y, Zhang X, Zhao J . Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic-polyribocytidilic acid. Psychiatry Res 2014; 219: 680\u2013686.","journal-title":"Psychiatry Res"},{"key":"BFtp201638_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.neubiorev.2009.05.001","volume":"33","author":"U Meyer","year":"2009","unstructured":"Meyer U, Feldon J, Fatemi SH . In vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 2009; 33: 1061\u20131079.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtp201638_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1196\/annals.1308.009","volume":"1021","author":"JN Giedd","year":"2004","unstructured":"Giedd JN . Structural magnetic resonance imaging of the adolescent brain. Ann NY Acad Sci 2004; 1021: 77\u201385.","journal-title":"Ann NY Acad Sci"},{"key":"BFtp201638_CR25","doi-asserted-by":"publisher","first-page":"8174","DOI":"10.1073\/pnas.0402680101","volume":"101","author":"N Gogtay","year":"2004","unstructured":"Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc. Proc Natl Acad Sci USA 2004; 101: 8174\u20138179.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp201638_CR26","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/nrn2513","volume":"9","author":"T Paus","year":"2008","unstructured":"Paus T, Keshavan M, Giedd JN . Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 2008; 9: 947\u2013957.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp201638_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","volume":"27","author":"RM Ransohoff","year":"2009","unstructured":"Ransohoff RM, Perry VH . Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009; 27: 119\u2013145.","journal-title":"Annu Rev Immunol"},{"key":"BFtp201638_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.brainres.2007.03.080","volume":"1154","author":"Y Levkovitz","year":"2007","unstructured":"Levkovitz Y, Levi U, Braw Y, Cohen H . Minocycline a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia. Brain Res 2007; 1154: 154\u2013162.","journal-title":"Brain Res"},{"key":"BFtp201638_CR29","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1038\/sj.npp.1301313","volume":"32","author":"L Zhang","year":"2007","unstructured":"Zhang L, Shirayama Y, Iyo M, Hashimoto K . Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine. Neuropsychopharmacology 2007; 32: 2004\u20132010.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201638_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0893-133X(01)00360-8","volume":"26","author":"J Borrell","year":"2002","unstructured":"Borrell J, Vela JM, Ar\u00e9valo-Martin A, Molina-Holgado E, Guaza C . Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 2002; 26: 204\u2013205.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201638_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.schres.2012.10.028","volume":"143","author":"MP Manitz","year":"2013","unstructured":"Manitz MP, Esslinger M, Wachholz S, Pl\u00fcmper J, Friebe A, Juckel G et al. The role of microglia during life span in neuropsychiatric disease\u2014an animal study. Schizophr Res 2013; 143: 221\u2013222.","journal-title":"Schizophr Res"},{"key":"BFtp201638_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/acps.12211","volume":"129","author":"G Fond","year":"2014","unstructured":"Fond G, Hamdani N, Kapczinski F, Boukouaci W, Drancourt N, Dargel A et al. Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr Scand 2014; 129: 163\u2013179.","journal-title":"Acta Psychiatr Scand"},{"key":"BFtp201638_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1177\/0269881112444941","volume":"26","author":"IB Chaudhry","year":"2012","unstructured":"Chaudhry IB, Hallak J, Husain N, Minhas F, Stirling J, Richardson P et al. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol 2012; 26: 1185\u20131193.","journal-title":"J Psychopharmacol"},{"key":"BFtp201638_CR34","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.psychres.2013.12.051","volume":"215","author":"MR Khodaie-Ardakani","year":"2014","unstructured":"Khodaie-Ardakani MR, Mirshafiee O, Farokhnia M, Tajdini M, Hosseini SM, Modabbernia A et al. Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study. Psychiatry Res 2014; 215: 540\u2013546.","journal-title":"Psychiatry Res"},{"key":"BFtp201638_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","volume":"71","author":"Y Levkovitz","year":"2010","unstructured":"Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G et al. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 2010; 71: 138\u2013149.","journal-title":"J Clin Psychiatry"},{"key":"BFtp201638_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.biopsych.2014.05.023","volume":"77","author":"TD Cannon","year":"2015","unstructured":"Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry 2015; 77: 147\u2013157.","journal-title":"Biol Psychiatry"},{"key":"BFtp201638_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/schbul\/sbu157","volume":"41","author":"M Kenk","year":"2015","unstructured":"Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G et al. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18\u2009F]-FEPPA. Schizophr Bull 2015; 41: 85\u201393.","journal-title":"Schizophr Bull"},{"key":"BFtp201638_CR38","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","volume":"71","author":"GM Khandaker","year":"2014","unstructured":"Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB . Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 2014; 71: 1121\u20131128.","journal-title":"JAMA Psychiatry"},{"key":"BFtp201638_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.schres.2014.07.031","volume":"161","author":"O Pasternak","year":"2015","unstructured":"Pasternak O, Westin CF, Dahlben B, Bouix S, Kubicki M . The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia. Schizophr Res 2015; 161: 113\u2013118.","journal-title":"Schizophr Res"},{"key":"BFtp201638_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbi.2015.06.004","volume":"49","author":"A Russell","year":"2015","unstructured":"Russell A, Ciufolini S, Gardner-Sood P, Bonaccorso S, Gaughran F, Dazzan P et al. Inflammation and metabolic changes in First Episode Psychosis: preliminary results from a longitudinal study. Brain Behav Immun 2015; 49: 25\u201329.","journal-title":"Brain Behav Immun"},{"key":"BFtp201638_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.neuroscience.2012.10.048","volume":"249","author":"L Eiland","year":"2013","unstructured":"Eiland L, Romeo RD . Stress and the developing adolescent brain. Neuroscience 2013; 249: 162\u2013171.","journal-title":"Neuroscience"},{"key":"BFtp201638_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00441-013-1581-2","volume":"354","author":"M Schneider","year":"2013","unstructured":"Schneider M . Adolescence as a vulnerable period to alter rodent behavior. Cell Tissue Res 2013; 354: 99\u2013106.","journal-title":"Cell Tissue Res"},{"key":"BFtp201638_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pnpbp.2011.11.003","volume":"42","author":"U Meyer","year":"2013","unstructured":"Meyer U . Developmental neuroinflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2013;42: 20\u201334.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp201638_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/neuro.08.014.2009","volume":"3","author":"SD Bilbo","year":"2009","unstructured":"Bilbo SD, Schwarz JM . Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 2009; 3: 14.","journal-title":"Front Behav Neurosci"},{"key":"BFtp201638_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS . Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8: 57\u201369.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp201638_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.brainres.2014.11.032","volume":"1617","author":"PM Bilimoria","year":"2015","unstructured":"Bilimoria PM, Stevens B . Microglia function during brain development: new insights from animal models. Brain Res 2015; 1617: 7\u201317.","journal-title":"Brain Res"},{"key":"BFtp201638_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.22389","volume":"61","author":"DP Schafer","year":"2013","unstructured":"Schafer DP, Lehrman EK, Stevens B . The \u2018quad-partite\u2019 synapse: microglia-synapse interactions in the developing and mature CNS. Glia 2013; 61: 24\u201336.","journal-title":"Glia"},{"key":"BFtp201638_CR48","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/187152709788680689","volume":"8","author":"D Orsucci","year":"2009","unstructured":"Orsucci D, Calsolaro V, Mancuso M, Siciliano G . Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease. CNS Neurol Disord Drug Targets 2009; 8: 222\u2013231.","journal-title":"CNS Neurol Disord Drug Targets"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp201638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201638","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:47:31Z","timestamp":1672822051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp201638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4]]}},"alternative-id":["BFtp201638"],"URL":"https:\/\/doi.org\/10.1038\/tp.2016.38","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]},"assertion":[{"value":"17 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}